We hypothesized that TGF-β may inhibit CD160 expression on total NK cells; therefore, we assessed plasma TGF-β levels in the HIV-infected group and NC group, and found that levels were higher during HIV infection (Figure 6A). The gene discussed is CD160; the disease is HIV infectious disease.